Entity

Time filter

Source Type

Novato, CA, United States

Patent
Ultragenyx Pharmaceutical | Date: 2015-03-05

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2013-01-18

The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.


Patent
Ultragenyx Pharmaceutical | Date: 2015-09-10

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical and Kyowa Hakko Kirin Co. | Date: 2015-05-29

The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.


The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).

Discover hidden collaborations